NL8703148A - Pyrimidinederivaten. - Google Patents

Pyrimidinederivaten. Download PDF

Info

Publication number
NL8703148A
NL8703148A NL8703148A NL8703148A NL8703148A NL 8703148 A NL8703148 A NL 8703148A NL 8703148 A NL8703148 A NL 8703148A NL 8703148 A NL8703148 A NL 8703148A NL 8703148 A NL8703148 A NL 8703148A
Authority
NL
Netherlands
Prior art keywords
general formula
hydrogen
compound
acid addition
reaction
Prior art date
Application number
NL8703148A
Other languages
English (en)
Dutch (nl)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU551286A external-priority patent/HU197913B/hu
Priority claimed from HU865514A external-priority patent/HU196763B/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NL8703148A publication Critical patent/NL8703148A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL8703148A 1986-12-30 1987-12-29 Pyrimidinederivaten. NL8703148A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU551286A HU197913B (en) 1986-12-30 1986-12-30 Process for producing thiazolo-, thiazino- and thiazepinopyrimidine derivatives
HU865514A HU196763B (en) 1986-12-30 1986-12-30 Process for production of piramidine-derivatives
HU551486 1986-12-30
HU551286 1986-12-30

Publications (1)

Publication Number Publication Date
NL8703148A true NL8703148A (nl) 1988-07-18

Family

ID=26317840

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8703148A NL8703148A (nl) 1986-12-30 1987-12-29 Pyrimidinederivaten.

Country Status (23)

Country Link
US (1) US4921854A (es)
KR (1) KR940002669B1 (es)
CN (1) CN1024277C (es)
AT (1) AT397802B (es)
AU (1) AU597770B2 (es)
BE (1) BE1003067A5 (es)
BG (1) BG82461A (es)
CA (1) CA1324788C (es)
CH (1) CH676599A5 (es)
DE (1) DE3743935A1 (es)
DK (1) DK692587A (es)
ES (1) ES2008945A6 (es)
FI (1) FI86637C (es)
FR (1) FR2609033B1 (es)
GB (1) GB2199581B (es)
GR (1) GR872084B (es)
IL (1) IL84988A0 (es)
NL (1) NL8703148A (es)
PH (1) PH24290A (es)
PL (1) PL149618B1 (es)
SE (1) SE8705196L (es)
SU (1) SU1650014A3 (es)
YU (2) YU46433B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921854A (en) * 1986-12-30 1990-05-01 Egis Gyogyszergyar Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds
DE102004035808A1 (de) * 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
RS60834B1 (sr) 2015-12-09 2020-10-30 Cadent Therapeutics Inc Modulatori heteroaromatskog nmda receptora i njihove upotrebe
EP4006038A1 (en) 2015-12-09 2022-06-01 Cadent Therapeutics, Inc. Thienopyrimidinone nmda receptor modulators and uses thereof
WO2018119374A1 (en) * 2016-12-22 2018-06-28 Cadent Therapeutics Nmda receptor modulators and uses thereof
CR20210125A (es) 2018-08-03 2021-06-30 Cadent Therapeutics Inc Moduladores del receptor nmda heteroaromático y usos de los mismos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2032686A1 (de) * 1970-07-02 1972-01-20 Dr Karl Thomae GmbH, 7950 Biberach Verfahren zur Herstellung von neuen 2 Aminoalkylamino thieno eckige Klammer auf 3,2 d eckige Klammer zu Pynmidinen
EP0049902A3 (en) * 1980-10-15 1982-09-01 Teijin Limited Novel thiazolo(3,2-a)pyrimidines, derivatives thereof, processes for production thereof, and pharmaceutical use thereof
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
DE3146300A1 (de) * 1981-11-17 1983-08-25 Schering AG, 1000 Berlin und 4709 Bergkamen Thiazolo- und (1,3)thiazino(3,2-b)(1,2,4)triazine, verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit selektiver herbizider wirkung
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
FR2574408B1 (fr) * 1984-12-12 1987-01-30 Rhone Poulenc Sante Procede de preparation d'isomeres optiques de thiazolo(3,2-a) pyrimidines, les nouveaux isomeres ainsi obtenus, les compositions pharmaceutiques qui les contiennent et les intermediaires pour mettre en oeuvre ce procede
US4921854A (en) * 1986-12-30 1990-05-01 Egis Gyogyszergyar Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds

Also Published As

Publication number Publication date
FI86637C (fi) 1992-09-25
US4921854A (en) 1990-05-01
ES2008945A6 (es) 1989-08-16
PL149618B1 (en) 1990-03-31
CN1024277C (zh) 1994-04-20
SE8705196L (sv) 1988-07-01
BG82461A (bg) 1993-12-24
FR2609033A1 (fr) 1988-07-01
IL84988A0 (en) 1988-06-30
CH676599A5 (es) 1991-02-15
SE8705196D0 (sv) 1987-12-30
GB2199581A (en) 1988-07-13
DK692587A (da) 1988-07-01
SU1650014A3 (ru) 1991-05-15
YU4989A (en) 1989-08-31
FI875766A0 (fi) 1987-12-30
AU597770B2 (en) 1990-06-07
FI86637B (fi) 1992-06-15
CA1324788C (en) 1993-11-30
FI875766A (fi) 1988-07-01
DK692587D0 (da) 1987-12-30
FR2609033B1 (fr) 1994-09-09
ATA345187A (de) 1993-11-15
GR872084B (en) 1988-04-27
PH24290A (en) 1990-05-29
GB2199581B (en) 1990-07-18
YU241987A (en) 1989-08-31
KR880007545A (ko) 1988-08-27
AT397802B (de) 1994-07-25
BE1003067A5 (fr) 1991-11-12
AU8314487A (en) 1988-06-30
CN87105992A (zh) 1988-08-10
DE3743935A1 (de) 1988-07-14
GB8730297D0 (en) 1988-02-03
YU46483B (sh) 1993-10-20
KR940002669B1 (ko) 1994-03-28
PL269811A1 (en) 1988-09-15
YU46433B (sh) 1993-10-20

Similar Documents

Publication Publication Date Title
US4267171A (en) C-5 Substituted cytosine nucleosides
FI73682C (fi) Foerfarande foer framstaellning av antiviralt 9-(1,3-dihydroxi-2-propoximetyl)guanin samt mellanprodukt.
US4000275A (en) Immunosuppressants
CN1950376B (zh) 莪术醇衍生物、含该衍生物的组合物及所述衍生物的制药用途
NO161372B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
US3669969A (en) BENZIMIDAZO {8 2,1-b{9 {0 QUINALOZIN-12-(6H)ONES
MX2014015249A (es) Derivados de segunda generacion del antibiotico antifungico anfotericina b de n-sustiduidos y metodos de su preparacion y aplicacion.
US7074925B1 (en) N-substituted derivatives of 5-oxyiminobarbituric acid
NL8703148A (nl) Pyrimidinederivaten.
GB2073752A (en) 2,6-diaminobularines
CZ390992A3 (en) Pyrimidine derivatives, process of their preparation and use as substances for increase of anti-tumor activity
US3560483A (en) 1,4-dialkyl-3,6-diphenylepi(thio,dithia or tetrathia)-2,5-piperazinediones
NL8403181A (nl) 4-chloorfuro(3,4-c)pyridinederivaten, werkwijzen ter bereiding ervan en farmaceutische preparaten, die hen bevatten.
JPH0114235B2 (es)
PT98167A (pt) Processo para a preparacao de derivados da pirimidina e de composicoes farmaceuticas que os contem
US4501744A (en) Substituted-aza-cytosine compounds and anti-viral uses thereof
CZ278692B6 (en) Process for preparing condensed pyrimidine derivatives
FI78301C (fi) Foerfarande foer framstaellning av nya bornanderivat.
GB2127809A (en) Certain beta -oxo- alpha -carbamoyl- pyrrolepropionitriles
US5126347A (en) Isomeric dideoxynuclesides
KR0140021B1 (ko) 피리미딘 아사이클로뉴클레오시드 유도체
RU2160260C1 (ru) Производное 4-оксо-1,4-дигидропиримидина, обладающее иммунодепрессивной активностью
JPH06172365A (ja) １０−チアイソアロキサジン誘導体およびその用途
CZ278709B6 (en) Process for preparing condensed pyrimidine derivatives
CS217731B1 (cs) Biologicky účinné basické ester-ethery 7-oxo-7H-benzo(c)fluorenu, jejich soli a způsob jejich přípravy

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
BT A notification was added to the application dossier and made available to the public
BV The patent application has lapsed